Miguel Montejo

4.0k total citations
27 papers, 1.3k citations indexed

About

Miguel Montejo is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Miguel Montejo has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Miguel Montejo's work include Antifungal resistance and susceptibility (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Miguel Montejo is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Miguel Montejo collaborates with scholars based in Spain, United States and Palestinian Territory. Miguel Montejo's co-authors include Patricia Muñóz, Jordi Carratalà, Jesús Fortün, Joan Gavaldà, Carlos Cervera, José Miguel Cisneros, Óscar Len, Asunción Moreno, António Ramos and José María Aguado and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Immunology and Transplantation.

In The Last Decade

Miguel Montejo

27 papers receiving 1.2k citations

Peers

Miguel Montejo
Peter Linden United States
Miguel Montejo
Citations per year, relative to Miguel Montejo Miguel Montejo (= 1×) peers Peter Linden

Countries citing papers authored by Miguel Montejo

Since Specialization
Citations

This map shows the geographic impact of Miguel Montejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Montejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Montejo more than expected).

Fields of papers citing papers by Miguel Montejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Montejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Montejo. The network helps show where Miguel Montejo may publish in the future.

Co-authorship network of co-authors of Miguel Montejo

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Montejo. A scholar is included among the top collaborators of Miguel Montejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Montejo. Miguel Montejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydillo, Teresa, Alba Escalera, Shirin Strohmeier, et al.. (2020). Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Reports Medicine. 1(8). 100130–100130. 21 indexed citations
2.
Cordero, Elisa, Ángel Bulnes‐Ramos, Manuela Aguilar‐Guisado, et al.. (2020). Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients. Frontiers in Immunology. 11. 1917–1917. 16 indexed citations
3.
Fortün, Jesús, Alfonso Muriel, Pilar Martín‐Dávila, et al.. (2015). Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high‐risk liver transplantation recipients: A propensity score analysis. Liver Transplantation. 22(4). 427–435. 32 indexed citations
4.
Cantisán, Sara, Cristian Rodelo‐Haad, Antonio Nieto, et al.. (2015). Factors Related to the Development of CMV-Specific CD8+ T cell Response in CMV-Seropositive Solid Organ Transplant Candidates. American Journal of Transplantation. 15(3). 715–722. 15 indexed citations
5.
Len, Óscar, Miguel Montejo, Carlos Cervera, et al.. (2014). Daptomycin is safe and effective for the treatment of gram‐positive cocci infections in solid organ transplantation. Transplant Infectious Disease. 16(4). 532–538. 8 indexed citations
6.
Puig‐Asensio, Mireia, B. Padilla, José Garnacho‐Montero, et al.. (2013). Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clinical Microbiology and Infection. 20(4). O245–O254. 224 indexed citations
7.
Gasch, Oriol, Mariana Camoez, M.Á. Domínguez, et al.. (2013). Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 68(6). 1423–1430. 35 indexed citations
8.
Len, Óscar, Dolors Rodríguez-Pardo, Joan Gavaldà, et al.. (2012). Outcome ofClostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study. Transplant International. 25(12). 1275–1281. 32 indexed citations
9.
Carratalà, Jordi, Miguel Montejo, & Pilar Pérez‐Romero. (2012). Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients. Enfermedades Infecciosas y Microbiología Clínica. 30. 63–69. 17 indexed citations
10.
Vidal, E., Marino Blanes, Miguel Montejo, et al.. (2012). Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transplant Infectious Disease. 14(6). 595–603. 125 indexed citations
11.
Cordero, Elisa, Pilar Pérez‐Romero, Asunción Moreno, et al.. (2011). Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clinical Microbiology and Infection. 18(1). 67–73. 50 indexed citations
12.
Juan, Rafael San, José María Aguado, Carlos Lumbreras, et al.. (2011). Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation. Liver Transplantation. 17(8). 896–904. 9 indexed citations
13.
López‐Medrano, Francisco, Mario Fernández‐Ruiz, José María Morales, et al.. (2011). Impact of Hepatitis C Virus Infection on the Risk of Infectious Complications After Kidney Transplantation: Data From the RESITRA/REIPI Cohort. Transplantation. 92(5). 543–549. 39 indexed citations
14.
Fortün, Jesús, Pilar Martín‐Dávila, Julio Pascual, et al.. (2010). Immunosuppressive therapy and infection after kidney transplantation. Transplant Infectious Disease. 12(5). 397–405. 53 indexed citations
15.
Fortün, Jesús, Pilar Martín‐Dávila, Miguel Montejo, et al.. (2009). Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients. Transplantation. 87(3). 424–435. 79 indexed citations
16.
Doblas, Antonio, José María Aguado, Rafael San Juan, et al.. (2009). Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort. Clinical Infectious Diseases. 48(12). 1657–1665. 198 indexed citations
17.
Len, Óscar, Joan Gavaldà, José María Aguado, et al.. (2008). Valganciclovir as Treatment for Cytomegalovirus Disease in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 46(1). 20–27. 46 indexed citations
18.
Ramos, António, Ángel Asensio, Elena Múñez, et al.. (2008). Incisional Surgical Site Infection in Kidney Transplantation. Urology. 72(1). 119–123. 35 indexed citations
19.
Moreno, Asunción, Carlos Cervera, Joan Gavaldà, et al.. (2007). Bloodstream Infections Among Transplant Recipients: Results of a Nationwide Surveillance in Spain1. American Journal of Transplantation. 7(11). 2579–2586. 168 indexed citations
20.
Montejo, Miguel, et al.. (1989). [Usefulness of ceftazidime and imipenem for the treatment of Pseudomonas aeruginosa meningitis. Study of 3 patients].. PubMed. 7(4). 224–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026